Published in J Virol on April 01, 2002
Virus entry, assembly, budding, and membrane rafts. Microbiol Mol Biol Rev (2003) 2.68
Heat shock protein 70 (hsp70) as an emerging drug target. J Med Chem (2010) 2.21
Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J Virol (2005) 1.83
Mechanisms of genetic robustness in RNA viruses. EMBO Rep (2006) 1.67
Integrin-using rotaviruses bind alpha2beta1 integrin alpha2 I domain via VP4 DGE sequence and recognize alphaXbeta2 and alphaVbeta3 by using VP7 during cell entry. J Virol (2003) 1.56
The role of mutational robustness in RNA virus evolution. Nat Rev Microbiol (2013) 1.54
Gene expression pattern in Caco-2 cells following rotavirus infection. J Virol (2002) 1.46
The heat shock cognate protein 70 is associated with hepatitis C virus particles and modulates virus infectivity. Hepatology (2009) 1.19
Interaction of rotaviruses with Hsc70 during cell entry is mediated by VP5. J Virol (2003) 1.08
Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells. J Virol (2004) 1.07
Different rotavirus strains enter MA104 cells through different endocytic pathways: the role of clathrin-mediated endocytosis. J Virol (2010) 1.06
Does Japanese encephalitis virus share the same cellular receptor with other mosquito-borne flaviviruses on the C6/36 mosquito cells? Virol J (2007) 1.06
A role for molecular chaperone Hsc70 in reovirus outer capsid disassembly. J Biol Chem (2007) 1.05
Rhesus rotavirus entry into a polarized epithelium is endocytosis dependent and involves sequential VP4 conformational changes. J Virol (2010) 1.00
Monkey rotavirus binding to alpha2beta1 integrin requires the alpha2 I domain and is facilitated by the homologous beta1 subunit. J Virol (2003) 0.93
Hsp70 negatively controls rotavirus protein bioavailability in caco-2 cells infected by the rotavirus RF strain. J Virol (2006) 0.93
The peptide-binding and ATPase domains of recombinant hsc70 are required to interact with rotavirus and reduce its infectivity. J Virol (2006) 0.92
The spike protein VP4 defines the endocytic pathway used by rotavirus to enter MA104 cells. J Virol (2012) 0.91
The soluble recombinant Neisseria meningitidis adhesin NadA(Δ351-405) stimulates human monocytes by binding to extracellular Hsp90. PLoS One (2011) 0.90
The heat shock response restricts virus infection in Drosophila. Sci Rep (2015) 0.87
VP7 mediates the interaction of rotaviruses with integrin alphavbeta3 through a novel integrin-binding site. J Virol (2004) 0.84
Active participation of cellular chaperone Hsp90 in regulating the function of rotavirus nonstructural protein 3 (NSP3). J Biol Chem (2011) 0.83
The salivary secretome of the tsetse fly Glossina pallidipes (Diptera: Glossinidae) infected by salivary gland hypertrophy virus. PLoS Negl Trop Dis (2011) 0.82
Nonprofessional phagocytic cell receptors involved in Staphylococcus aureus internalization. Biomed Res Int (2014) 0.82
HSP70 induced by Hantavirus infection interacts with viral nucleocapsid protein and its overexpression suppresses virus infection in Vero E6 cells. Am J Transl Res (2009) 0.80
Participation of ezrin in bacterial uptake by trophoblast giant cells. Reprod Biol Endocrinol (2009) 0.79
Inhibition of HSP70 reduces porcine reproductive and respiratory syndrome virus replication in vitro. BMC Microbiol (2014) 0.78
Inhibition of rotavirus ECwt infection in ICR suckling mice by N-acetylcysteine, peroxisome proliferator-activated receptor gamma agonists and cyclooxygenase-2 inhibitors. Mem Inst Oswaldo Cruz (2013) 0.78
Anti-HBV efficacy of combined siRNAs targeting viral gene and heat shock cognate 70. Virol J (2012) 0.78
Structural correlates of rotavirus cell entry. PLoS Pathog (2014) 0.78
Theiler's murine encephalomyelitis virus infection induces a redistribution of heat shock proteins 70 and 90 in BHK-21 cells, and is inhibited by novobiocin and geldanamycin. Cell Stress Chaperones (2011) 0.77
M1 of Murine Gamma-Herpesvirus 68 Induces Endoplasmic Reticulum Chaperone Production. Sci Rep (2015) 0.77
Cellular transcripts of chicken brain tissues in response to H5N1 and Newcastle disease virus infection. Virol J (2012) 0.77
Persistent borna disease virus infection confers instability of HSP70 mRNA in glial cells during heat stress. J Virol (2005) 0.77
GHSC70 is involved in the cellular entry of nervous necrosis virus. J Virol (2014) 0.77
Inflammatory and oxidative stress in rotavirus infection. World J Virol (2016) 0.76
Human Heat shock protein 40 (Hsp40/DnaJB1) promotes influenza A virus replication by assisting nuclear import of viral ribonucleoproteins. Sci Rep (2016) 0.75
The SRL peptide of Rhesus Rotavirus VP4 protein governs cholangiocyte infection and the murine model of biliary atresia. Hepatology (2016) 0.75
Experimental Adaptation of Rotaviruses to Tumor Cell Lines. PLoS One (2016) 0.75
Evidence that Hsc70 is associated with CNV particles and plays a role in CNV particle disassembly. J Virol (2016) 0.75
Molecular chaperones in cellular protein folding. Nature (1996) 14.00
The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature (1995) 12.25
Virus receptors: binding, adhesion strengthening, and changes in viral structure. J Virol (1994) 2.92
Folding of VSV G protein: sequential interaction with BiP and calnexin. Science (1994) 2.45
The heat-shock response: regulation and function of heat-shock proteins and molecular chaperones. Essays Biochem (1997) 2.24
A stress-inducible 72-kDa heat-shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells. Int J Cancer (1995) 2.12
Unusual expression and localization of heat-shock proteins in human tumor cells. Int J Cancer (1992) 2.12
Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. J Immunol (1999) 1.92
Dominant-interfering Hsc70 mutants disrupt multiple stages of the clathrin-coated vesicle cycle in vivo. J Cell Biol (2001) 1.81
Human and most animal rotavirus strains do not require the presence of sialic acid on the cell surface for efficient infectivity. J Gen Virol (1999) 1.73
Integrins alpha2beta1 and alpha4beta1 can mediate SA11 rotavirus attachment and entry into cells. J Virol (2000) 1.72
Comparison of human, simian, and bovine rotaviruses for requirement of sialic acid in hemagglutination and cell adsorption. Virology (1989) 1.71
Integrin alpha(v)beta(3) mediates rotavirus cell entry. Proc Natl Acad Sci U S A (2000) 1.56
In vivo and in vitro association of hsc70 with polyomavirus capsid proteins. J Virol (1995) 1.52
Biochemical characterization of rotavirus receptors in MA104 cells. J Virol (2000) 1.52
Hsp70 chaperone systems: diversity of cellular functions and mechanism of action. Biol Chem (1998) 1.51
Glycosphingolipid binding specificities of rotavirus: identification of a sialic acid-binding epitope. J Virol (2001) 1.51
Binding to sialic acids is not an essential step for the entry of animal rotaviruses to epithelial cells in culture. J Virol (1993) 1.50
Low-pH induced conformational changes in viral fusion proteins: implications for the fusion mechanism. J Gen Virol (1995) 1.50
Cell surface expression of heat shock proteins and the immune response. Cell Stress Chaperones (1996) 1.48
Structure and function of a ganglioside receptor for porcine rotavirus. J Virol (1998) 1.39
Association of heat shock protein 70 with enterovirus capsid precursor P1 in infected human cells. J Virol (1992) 1.38
Nuclear import of adenovirus DNA in vitro involves the nuclear protein import pathway and hsc70. J Biol Chem (2000) 1.36
Vaccinia virus infection induces a stress response that leads to association of Hsp70 with viral proteins. J Virol (1992) 1.36
Definition of extracellular localized epitopes of Hsp70 involved in an NK immune response. Cell Stress Chaperones (1998) 1.36
Activation of heat-shock response by an adenovirus is essential for virus replication. Nature (2000) 1.34
ATP and ADP modulate a cation channel formed by Hsc70 in acidic phospholipid membranes. J Biol Chem (2000) 1.28
Ganglioside GM(1a) on the cell surface is involved in the infection by human rotavirus KUN and MO strains. J Biochem (1999) 1.27
Entry of rotaviruses is a multistep process. Virology (1999) 1.25
Characterization of binding of simian rotavirus SA-11 to cultured epithelial cells. J Pediatr Gastroenterol Nutr (1988) 1.19
Identification of heat shock protein 70 in the rabies virion. Virology (1992) 1.19
Saturation, competition, and specificity in interaction of heat shock proteins (hsp) gp96, hsp90, and hsp70 with CD11b+ cells. J Immunol (2000) 1.19
Enhanced measles virus cDNA rescue and gene expression after heat shock. J Virol (1999) 1.18
Hsp90 phosphorylation is linked to its chaperoning function. Assembly of the reovirus cell attachment protein. J Biol Chem (2001) 1.17
The VP5 domain of VP4 can mediate attachment of rotaviruses to cells. J Virol (2000) 1.16
Integrin alpha2beta1 mediates the cell attachment of the rotavirus neuraminidase-resistant variant nar3. Virology (2000) 1.16
Fluorescence recovery after photobleaching reveals that LPS rapidly transfers from CD14 to hsp70 and hsp90 on the cell membrane. J Cell Sci (2001) 1.16
Involvement of the molecular chaperone BiP in maturation of Sindbis virus envelope glycoproteins. J Virol (1995) 1.13
Chaperones involved in hepatitis B virus morphogenesis. Biol Chem (1999) 1.09
Human hepatitis B virus polymerase interacts with the molecular chaperonin Hsp60. J Virol (2001) 1.08
Binding of reovirus to receptor leads to conformational changes in viral capsid proteins that are reversible upon virus detachment. J Biol Chem (1994) 1.06
Members of the 70 kDa heat shock protein family specifically recognize sulfoglycolipids: role in gamete recognition and mycoplasma-related infertility. J Cell Physiol (1995) 1.04
71-kilodalton heat shock cognate protein acts as a cellular receptor for syncytium formation induced by human T-cell lymphotropic virus type 1. J Virol (1998) 1.01
New insights suggesting a possible role of a heat shock protein 70-kD family-related protein in antigen processing/presentation phenomenon in humans. Blood (1993) 1.01
Heat shock cognate protein 70 is a cell fusion-enhancing factor but not an entry factor for human T-cell lymphotropic virus type I. Biochem Biophys Res Commun (1999) 0.89
Enhanced production of morbillivirus gene-specific RNAs following induction of the cellular stress response in stable persistent infection. Virology (1993) 0.88
Heat-shock proteins expressed on the surface of human T cell leukemia virus type I-infected cell lines induce autoantibodies in rabbits. J Infect Dis (1994) 0.87
A 60 kD heat-shock protein-like molecule interacts with the HIV transmembrane glycoprotein gp41. Mol Immunol (1999) 0.86
Early events of rotavirus infection: the search for the receptor(s). Novartis Found Symp (2001) 0.85
HSC70 interactions with SV40 viral proteins differ between permissive and nonpermissive mammalian cells. Cell Stress Chaperones (2000) 0.85
Characterization and cellular distribution of human spermatozoal heat shock proteins. Hum Reprod (1992) 0.85
Stress responses to viral infection. Trends Microbiol (1994) 0.84
Heat shock protein-based therapeutic strategies against human immunodeficiency virus type 1 infection. Infect Dis Obstet Gynecol (1999) 0.84
Characterization of a monoclonal antibody directed to the surface of MA104 cells that blocks the infectivity of rotaviruses. Virology (2000) 0.82
A new insight into the suggestion of a possible antigenic role of a member of the 70 kD heat shock proteins. Cell Biol Int (1993) 0.78
The Pathway Tools software. Bioinformatics (2002) 14.89
TLR3 deficiency in patients with herpes simplex encephalitis. Science (2007) 5.86
Flexible nets. The roles of intrinsic disorder in protein interaction networks. FEBS J (2005) 5.36
Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity (2011) 3.97
Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance. Cancer Res (2004) 3.59
Exhaustion of tumor-specific CD8⁺ T cells in metastases from melanoma patients. J Clin Invest (2011) 3.28
Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI). Cancer Immunol Immunother (2007) 3.16
Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909. J Clin Invest (2005) 3.11
Tumour immunity: effector response to tumour and role of the microenvironment. Lancet (2008) 2.94
Coupled folding and binding with alpha-helix-forming molecular recognition elements. Biochemistry (2005) 2.94
"MIATA"-minimal information about T cell assays. Immunity (2009) 2.90
The unfoldomics decade: an update on intrinsically disordered proteins. BMC Genomics (2008) 2.72
Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rheum (2008) 2.15
A metagenomic analysis of pandemic influenza A (2009 H1N1) infection in patients from North America. PLoS One (2010) 1.99
Mining alpha-helix-forming molecular recognition features with cross species sequence alignments. Biochemistry (2007) 1.93
EDEM3, a soluble EDEM homolog, enhances glycoprotein endoplasmic reticulum-associated degradation and mannose trimming. J Biol Chem (2006) 1.91
Harmonization of immune biomarker assays for clinical studies. Sci Transl Med (2011) 1.84
Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur J Immunol (2009) 1.81
Cooperation of human tumor-reactive CD4+ and CD8+ T cells after redirection of their specificity by a high-affinity p53A2.1-specific TCR. Immunity (2005) 1.81
Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions. Blood (2003) 1.78
D²P²: database of disordered protein predictions. Nucleic Acids Res (2012) 1.75
New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site. J Immunol (2006) 1.74
BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination. J Clin Invest (2009) 1.71
Melan-A/MART-1-specific CD8 T cells: from thymus to tumor. Trends Immunol (2002) 1.68
In vivo imaging of T cell delivery to tumors after adoptive transfer therapy. Proc Natl Acad Sci U S A (2007) 1.65
Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium. Cancer Immunol Immunother (2009) 1.63
Multistep entry of rotavirus into cells: a Versaillesque dance. Trends Microbiol (2004) 1.62
Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses. Proc Natl Acad Sci U S A (2009) 1.61
Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigen. Proc Natl Acad Sci U S A (2008) 1.59
Rational drug design via intrinsically disordered protein. Trends Biotechnol (2006) 1.57
Silencing the morphogenesis of rotavirus. J Virol (2005) 1.55
Toll-like receptor 3 expressed by melanoma cells as a target for therapy? Clin Cancer Res (2007) 1.55
Rotavirus vaccine: early introduction in Latin America-risks and benefits. Arch Med Res (2006) 1.53
MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer. Immunity (2013) 1.51
Improving protein order-disorder classification using charge-hydropathy plots. BMC Bioinformatics (2014) 1.50
Rotavirus infection induces the phosphorylation of eIF2alpha but prevents the formation of stress granules. J Virol (2007) 1.49
Discovery of a novel polyomavirus in acute diarrheal samples from children. PLoS One (2012) 1.48
Follow-up of children with autoimmune hepatitis treated with cyclosporine. J Pediatr Gastroenterol Nutr (2006) 1.47
Characterization of rotavirus cell entry. J Virol (2004) 1.46
Transcriptional profiling of Caulobacter crescentus during growth on complex and minimal media. J Bacteriol (2004) 1.46
Thymic selection generates a large T cell pool recognizing a self-peptide in humans. J Exp Med (2002) 1.44
Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity. Oncogene (2002) 1.42
Conservation of intrinsic disorder in protein domains and families: I. A database of conserved predicted disordered regions. J Proteome Res (2006) 1.42
Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population. Eur J Intern Med (2003) 1.41
Rotavirus gene silencing by small interfering RNAs. EMBO Rep (2002) 1.36
Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function. J Immunol (2010) 1.33
Immuno-monitoring of CD8+ T cells in whole blood versus PBMC samples. J Immunol Methods (2005) 1.33
The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis. J Immunol (2009) 1.32
Toll-like receptors' two-edged sword: when immunity meets apoptosis. Eur J Immunol (2007) 1.32
Inhibition of cellular autophagy deranges dengue virion maturation. J Virol (2012) 1.32
Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells. Cancer Res (2012) 1.30
Ex vivo detectable activation of Melan-A-specific T cells correlating with inflammatory skin reactions in melanoma patients vaccinated with peptides in IFA. Cancer Immun (2004) 1.29
Human effector CD8+ T lymphocytes express TLR3 as a functional coreceptor. J Immunol (2006) 1.28
Role of sialic acids in rotavirus infection. Glycoconj J (2006) 1.28
Efficient transduction of dendritic cells and induction of a T-cell response by third-generation lentivectors. Hum Gene Ther (2002) 1.27
Ex vivo analysis of human antigen-specific CD8+ T-cell responses: quality assessment of fluorescent HLA-A2 multimer and interferon-gamma ELISPOT assays for patient immune monitoring. J Immunother (2004) 1.27
Conservation of intrinsic disorder in protein domains and families: II. functions of conserved disorder. J Proteome Res (2006) 1.27
Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression. Cancer Res (2011) 1.25
Enrichment of human CD4+ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors. J Immunol (2009) 1.25
Selecting highly affine and well-expressed TCRs for gene therapy of melanoma. Blood (2007) 1.25
Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-a peptide multimer(+) CD8(+) T cells in humans. J Exp Med (2002) 1.25
Exploring the binding diversity of intrinsically disordered proteins involved in one-to-many binding. Protein Sci (2013) 1.23
Caspases mediate processing of the capsid precursor and cell release of human astroviruses. J Virol (2004) 1.21
Reduced expression of the rotavirus NSP5 gene has a pleiotropic effect on virus replication. J Gen Virol (2005) 1.21
Proteolytic processing of a serotype 8 human astrovirus ORF2 polyprotein. J Virol (2002) 1.20
Regulation of monocyte functional heterogeneity by miR-146a and Relb. Cell Rep (2012) 1.19
Influence of calcium on the early steps of rotavirus infection. Virology (2002) 1.17
Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+ T-cell responses. J Clin Oncol (2003) 1.17
The rotavirus surface protein VP8 modulates the gate and fence function of tight junctions in epithelial cells. J Cell Sci (2004) 1.17
Functional avidity of tumor antigen-specific CTL recognition directly correlates with the stability of MHC/peptide multimer binding to TCR. J Immunol (2002) 1.17
Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance. J Clin Invest (2014) 1.16
Interplay between T cell receptor binding kinetics and the level of cognate peptide presented by major histocompatibility complexes governs CD8+ T cell responsiveness. J Biol Chem (2012) 1.16
NLRC5 deficiency selectively impairs MHC class I- dependent lymphocyte killing by cytotoxic T cells. J Immunol (2012) 1.14
TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer. Cancer Res (2011) 1.14
Dextramers: new generation of fluorescent MHC class I/peptide multimers for visualization of antigen-specific CD8+ T cells. J Immunol Methods (2006) 1.13
Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets. J Transl Med (2011) 1.13
Rotavirus Nonstructural Protein NSP3 is not required for viral protein synthesis. J Virol (2006) 1.13
A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses: spontaneous priming and efficient boosting by vaccination. J Immunol (2006) 1.13
Combination of lentivector immunization and low-dose chemotherapy or PD-1/PD-L1 blocking primes self-reactive T cells and induces anti-tumor immunity. Eur J Immunol (2011) 1.13
Molecular design of the Calphabeta interface favors specific pairing of introduced TCRalphabeta in human T cells. J Immunol (2008) 1.12
Ex vivo detectable human CD8 T-cell responses to cancer-testis antigens. Cancer Res (2006) 1.11
Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity. J Immunol (2002) 1.11
In vivo activation of melanoma-specific CD8(+) T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cells. Eur J Immunol (2002) 1.10
Fine structural variations of alphabetaTCRs selected by vaccination with natural versus altered self-antigen in melanoma patients. J Immunol (2009) 1.09